Overview

Clinical Effect and Safety of Autologous Umbilical Cord Blood Transfusion in the Treatment of Autism Spectrum Disorder

Status:
Recruiting

Trial end date:
2024-12-31

Target enrollment:
0

Participant gender:
All

Summary

To study the clinical efficacy and safety of autologous umbilical cord blood transfusion in the treatment of autism spectrum disorder.

Phase:

Phase 1

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Guangdong Women and Children Hospital

Criteria

Inclusion Criteria:

- • A patient who was diagnosed with ASD.

Exclusion Criteria:

- • In case a patient underwent a surgical procedure, or was administered autologous
cord blood within one year before participating in a clinical trial.

- Accompanied by a serious disease, such as chromosome abnormality, etc.

- In case where a patient's medical condition is judged to be maladapted by a
researcher.

- In case a patient or his or her legal representative doesn't agree to
participation in a clinical trial.

- A patient having a predisposition to allergies.

- A patient having serious disorders in the liver, kidney, and cardiopulmonary
function.